• THE AI NEWS
  • Posts
  • OpenAI Expands to Japan, Tesla Cuts Costs!

OpenAI Expands to Japan, Tesla Cuts Costs!

In partnership with

Welcome,Tech Trailblazers and Digital Dreamers!

This week's tech news is hotter than a freshly overclocked CPU!

First up, OpenAI is saying "Konnichiwa" to Japan! That's right, folks - they're setting up shop in Tokyo and unleashing a Japanese-speaking GPT-4. It's like giving AI a crash course in sushi and anime! Watch out, tech giants - OpenAI's coming for your bento box!

Additionally, Elon Musk is playing musical chairs at Tesla, and not everyone's getting a seat. He's trimming the workforce by over 10​%! Looks like some Teslas are running on a leaner engine these days. Is it a smart move, or just Musk being, well, Musk? O​nly time will tell!

In other news:

  • Rubrik's IPO p​rice tag got leaked. Oops! Someone's spreadsheet needs better security!

  • ShareChat's value took a nosedive. Guess not a​ll chats are created equal!

  • Smartphones are selling like hotcakes again. Welcome back, pocket-sized overlords!

N​ow, let's zoom out for a second. OpenAI's Japan adventure? It's like watching a chess match where the players are countries, and AI is the queen. And Tesla's workforce di​et? It's Elon's way of saying, "EVs are cool, but have you tried efficiency?"

So, what's next in this tech tango? Will OpenAI's Japanese GPT-4 start writing haikus? Will Tesla employees start carpooling in Cybertrucks? Stay tuned, folks - in the tech world, tomorrow's always just a software update away!

Keep innovating, questioning, and remembering - in tech, the o​nly constant is change!

Your AI-obsessed, EV-enthused buddy

THE AI NEWS Team

P.S. See the full story unfold — watch on The AI News YouTube!

P.P.S. Got any wild predictions for the next big tech shake-up? Drop 'em in the comments - let's g​et our geek on!

Pioneering medicine starts with investors like you.

Cizzle Biotech is transforming lung cancer detection with a patented, 95% accurate blood test. By joining our raise, you’ll gain ownership in a company backed by partnerships with Bio-Techne and Moffitt Cancer Center. You can build your portfolio with a stake in a medical breakthrough.

Read the Offering information carefully before investing. It contains details of the issuer’s business, risks, charges, expenses, and other information, which should be considered before investing. Obtain a Form C and Offering Memorandum at invest.cizzlebio.com